Search results
Prothrombin activator Ecarin
Activation of prothrombin.
CoaChrom® α2-Macroglobulin
Determination of α2‐macroglobulin (α2‐M) in human plasma. For research use only.
MRX Calcium Chloride
MRX Calcium Chloride is intended to be used to add calcium ions to the citrated human plasma samples in the MRX APTT assays.
MRX PBS Diluent
For dilution (not for reconstitution) of calibrators, controls, and patient samples.
CRYOcheck Factor VIII Inhibitor Kit, frozen
The CE marked kit is ideal for laboratories seeking to standardize sample preparation to limit variability in their MNBA. Each kit contains five vial sets—enough to prepare five patient samples—including positive and negative FVIII inhibitor controls Excellent repeatability and reproducibility; suitable for multi-center clinical studies Excellent linearity across a broad reportable range Convenient frozen format—ready to use within minutes, no reconstitution errors Further information available here Please find the safety data sheet for the controls included in the kit by clicking the MSDS download button below. Please find the safety data sheet for the included component IB-PNP here . Please find the safety data sheet for the included component IB-BSA here .
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Collagen
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome, storage pool disease) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Arachidonic Acid
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
ADP Assay for Platelet Aggregation
Investigation of congenital (e.g. Glanzmann’s thrombasthenia, Bernard-Soulier, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma, hepatic or renal failure). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
Aprotinin
Aprotinin can be used in any application where inhibition of its targeted proteases is needed. Current uses include protein isolation, removal of reactive proteases through solid phase, inhibition of undesired proteolytic activity in laboratory assays, or other techniques; for blocking fibrinolytic activity in vitro; etc.